Targeting mir130b-IL-33-PD-L1 axis effectively inhibits esophageal squamous carcinoma progression

Ying Yue, Wei Xian, Yi Yuan, Xinyue Wang, Peng Wu, Xiaoyu Sha, Xiangyu Yue · 2026

Read Targeting mir130b-IL-33-PD-L1 axis effectively inhibits esophageal squamous carcinoma progression by Ying Yue, Wei Xian, Yi Yuan, Xinyue Wang, Peng Wu, Xiaoyu Sha, Xiangyu Yue (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13158390.txt.

Description

Ying Yue and six co-authors report a 2026 study on a signal chain that helps throat cancer grow and hide from the immune system. One link is a signal protein, IL-33, that is high in these tumors and tracks with late stage and poor outlook. Another link is the brake protein PD-L1, which tumors use to switch immune attacks off.

The team found that IL-33 raises PD-L1 and speeds tumor spread, and that blocking PD-L1 cuts the harm. A small RNA reins the chain in by silencing the switch that turns IL-33 on. Mice given more of that RNA grew smaller tumors with lower IL-33 and PD-L1. The two proteins also rose together across many cancer types. The authors name the chain a target for new treatment.

Catalog record

CREATORYing Yue, Wei Xian, Yi Yuan, Xinyue Wang, Peng Wu, Xiaoyu Sha, Xiangyu Yue
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13158390

Browse the full library · About the Tower of Babel